MAPK1 and Alzheimer disease: Mechanistically, miR-132 inhibited the expression of iNOS and oxidative stress in the hippocampus by inhibiting the expression of MAPK1, and improved the cognitive function of AD rats, which was helpful for understanding the pathogenesis of AD and developing new clinical treatments (48).